Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

CEBPA MUTATION

Clinical trials for CEBPA MUTATION explained in plain language.

Never miss a new study

Get alerted when new CEBPA MUTATION trials appear

Sign up with your email to follow new studies for CEBPA MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • New combo offers hope for Tough-to-Treat leukemia

    Disease control Recruiting now

    This study tests a combination of three drugs (venetoclax, a hypomethylating agent, and low-dose cytarabine) in adults newly diagnosed with a specific genetic subtype of acute myeloid leukemia (CEBPA-mutated) who cannot tolerate strong chemotherapy. The goal is to see if this tre…

    Matched conditions: CEBPA MUTATION

    Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

    Last updated May 12, 2026 13:42 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space